Athena Kantartzis Petrides, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tandem Mass Spectrometry | 10 | 2020 | 1157 | 1.440 |
Why?
|
Clinical Laboratory Information Systems | 3 | 2017 | 108 | 1.240 |
Why?
|
Urinalysis | 5 | 2021 | 369 | 1.010 |
Why?
|
Substance Abuse Detection | 5 | 2021 | 283 | 1.010 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2020 | 1572 | 0.880 |
Why?
|
Chromatography, Liquid | 7 | 2021 | 976 | 0.860 |
Why?
|
Drug Monitoring | 2 | 2019 | 956 | 0.840 |
Why?
|
Automation, Laboratory | 1 | 2021 | 101 | 0.770 |
Why?
|
Laboratories | 5 | 2021 | 463 | 0.710 |
Why?
|
Glucuronides | 1 | 2019 | 20 | 0.690 |
Why?
|
Analgesia, Obstetrical | 1 | 2020 | 177 | 0.650 |
Why?
|
Fentanyl | 1 | 2020 | 410 | 0.600 |
Why?
|
Analgesia, Epidural | 1 | 2020 | 327 | 0.580 |
Why?
|
Body Fluids | 1 | 2018 | 319 | 0.550 |
Why?
|
Analgesics, Opioid | 4 | 2021 | 3674 | 0.510 |
Why?
|
Citalopram | 2 | 2015 | 403 | 0.500 |
Why?
|
Hospital Information Systems | 1 | 2017 | 395 | 0.490 |
Why?
|
Sertraline | 1 | 2014 | 206 | 0.450 |
Why?
|
Efficiency, Organizational | 1 | 2017 | 695 | 0.430 |
Why?
|
Bupropion | 1 | 2014 | 303 | 0.420 |
Why?
|
Electronic Health Records | 4 | 2017 | 4468 | 0.420 |
Why?
|
Creatinine | 3 | 2021 | 1919 | 0.410 |
Why?
|
Benzodiazepines | 1 | 2018 | 1101 | 0.410 |
Why?
|
Prescription Drugs | 1 | 2019 | 595 | 0.400 |
Why?
|
Limit of Detection | 4 | 2020 | 265 | 0.390 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2011 | 436 | 0.320 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.280 |
Why?
|
RNA, Small Nuclear | 3 | 2011 | 65 | 0.280 |
Why?
|
Blood Specimen Collection | 2 | 2017 | 246 | 0.260 |
Why?
|
Workflow | 2 | 2021 | 847 | 0.250 |
Why?
|
Cardiology | 1 | 2015 | 1668 | 0.230 |
Why?
|
Trinucleotide Repeat Expansion | 2 | 2020 | 243 | 0.230 |
Why?
|
Spliceosomes | 2 | 2011 | 110 | 0.230 |
Why?
|
MutS Homolog 2 Protein | 1 | 2012 | 200 | 0.210 |
Why?
|
Saccharomyces cerevisiae | 3 | 2020 | 2752 | 0.200 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2020 | 1888 | 0.200 |
Why?
|
Pseudouridine | 1 | 2011 | 24 | 0.190 |
Why?
|
Apgar Score | 1 | 2020 | 123 | 0.180 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 263 | 0.180 |
Why?
|
Infant, Newborn | 1 | 2020 | 25625 | 0.180 |
Why?
|
Molecular Biology | 2 | 2023 | 596 | 0.180 |
Why?
|
Bicycling | 1 | 2020 | 176 | 0.170 |
Why?
|
Chromatography, Reverse-Phase | 1 | 2018 | 22 | 0.170 |
Why?
|
Trinucleotide Repeats | 1 | 2020 | 261 | 0.170 |
Why?
|
Hallucinogens | 1 | 2021 | 180 | 0.160 |
Why?
|
Laboratories, Hospital | 2 | 2017 | 194 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.160 |
Why?
|
DNA, Single-Stranded | 1 | 2020 | 354 | 0.160 |
Why?
|
Maternal Age | 1 | 2020 | 802 | 0.150 |
Why?
|
Cocaine-Related Disorders | 1 | 2020 | 460 | 0.140 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2017 | 115 | 0.140 |
Why?
|
Attitude to Computers | 1 | 2017 | 202 | 0.140 |
Why?
|
Outpatients | 2 | 2021 | 1486 | 0.140 |
Why?
|
Reproducibility of Results | 4 | 2019 | 19905 | 0.140 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.130 |
Why?
|
Automobile Driving | 1 | 2020 | 431 | 0.130 |
Why?
|
Blood Chemical Analysis | 1 | 2017 | 440 | 0.130 |
Why?
|
Cannabis | 1 | 2021 | 439 | 0.130 |
Why?
|
Saliva | 1 | 2019 | 809 | 0.130 |
Why?
|
Immunoassay | 1 | 2018 | 752 | 0.130 |
Why?
|
Accidents, Traffic | 1 | 2020 | 819 | 0.120 |
Why?
|
Solid Phase Extraction | 1 | 2014 | 28 | 0.120 |
Why?
|
False Negative Reactions | 1 | 2015 | 588 | 0.120 |
Why?
|
Drug Stability | 1 | 2014 | 291 | 0.120 |
Why?
|
Genetic Techniques | 1 | 2017 | 435 | 0.120 |
Why?
|
Bone Marrow | 1 | 2023 | 2948 | 0.110 |
Why?
|
Walking | 1 | 2020 | 1180 | 0.110 |
Why?
|
Tacrolimus | 1 | 2016 | 743 | 0.110 |
Why?
|
DNA Repair | 1 | 2012 | 2046 | 0.110 |
Why?
|
Antifungal Agents | 1 | 2017 | 730 | 0.110 |
Why?
|
Humans | 29 | 2023 | 744343 | 0.100 |
Why?
|
Buprenorphine | 1 | 2019 | 640 | 0.100 |
Why?
|
Skin Transplantation | 1 | 2016 | 1074 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1071 | 0.100 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.090 |
Why?
|
Patient Compliance | 1 | 2019 | 2684 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1972 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2018 | 1916 | 0.080 |
Why?
|
Amyloidosis | 1 | 2015 | 795 | 0.080 |
Why?
|
DNA | 1 | 2012 | 7301 | 0.080 |
Why?
|
Dopamine | 1 | 2015 | 1591 | 0.080 |
Why?
|
Substance-Related Disorders | 2 | 2020 | 4258 | 0.070 |
Why?
|
Nucleic Acid Conformation | 2 | 2011 | 913 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2015 | 812 | 0.070 |
Why?
|
Graft Survival | 1 | 2016 | 3737 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2065 | 0.070 |
Why?
|
RNA Splicing | 2 | 2011 | 907 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9648 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3396 | 0.060 |
Why?
|
Base Sequence | 3 | 2011 | 12797 | 0.060 |
Why?
|
Graft Rejection | 1 | 2016 | 4397 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3843 | 0.060 |
Why?
|
DNA Ligases | 1 | 2012 | 80 | 0.050 |
Why?
|
Time Factors | 3 | 2019 | 40075 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2014 | 2838 | 0.050 |
Why?
|
Myotonic Dystrophy | 1 | 2012 | 78 | 0.050 |
Why?
|
DNA Repair Enzymes | 1 | 2012 | 349 | 0.050 |
Why?
|
RNA, Fungal | 1 | 2011 | 164 | 0.050 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 2010 | 47 | 0.050 |
Why?
|
Ribonuclease H | 1 | 2010 | 45 | 0.050 |
Why?
|
Hospitalization | 2 | 2021 | 10262 | 0.050 |
Why?
|
Legislation, Drug | 1 | 2021 | 206 | 0.040 |
Why?
|
Uridine | 1 | 2010 | 146 | 0.040 |
Why?
|
Female | 9 | 2023 | 380194 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14722 | 0.040 |
Why?
|
Xenopus | 1 | 2011 | 712 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6171 | 0.040 |
Why?
|
RNA, Ribosomal | 1 | 2010 | 246 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29144 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2011 | 528 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2012 | 839 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15519 | 0.040 |
Why?
|
Itraconazole | 1 | 2017 | 43 | 0.040 |
Why?
|
Nucleic Acid Denaturation | 1 | 2017 | 111 | 0.040 |
Why?
|
Fluconazole | 1 | 2017 | 146 | 0.040 |
Why?
|
Naloxone | 1 | 2019 | 367 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2010 | 18111 | 0.040 |
Why?
|
Phlebotomy | 1 | 2017 | 141 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2020 | 684 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 981 | 0.030 |
Why?
|
Oocytes | 1 | 2011 | 1187 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2016 | 642 | 0.030 |
Why?
|
Huntington Disease | 1 | 2012 | 1124 | 0.030 |
Why?
|
Genomic Instability | 1 | 2020 | 695 | 0.030 |
Why?
|
Trauma Centers | 1 | 2020 | 890 | 0.030 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 562 | 0.030 |
Why?
|
Analgesics | 1 | 2021 | 1040 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.030 |
Why?
|
Adult | 4 | 2021 | 214055 | 0.030 |
Why?
|
Documentation | 1 | 2019 | 871 | 0.030 |
Why?
|
DNA Replication | 1 | 2020 | 1399 | 0.030 |
Why?
|
DNA Primers | 1 | 2017 | 2892 | 0.030 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2015 | 503 | 0.030 |
Why?
|
Triazoles | 1 | 2017 | 911 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 213383 | 0.020 |
Why?
|
Models, Molecular | 1 | 2011 | 5456 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1842 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1257 | 0.020 |
Why?
|
Phosphorylation | 1 | 2010 | 8436 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77449 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Animals | 4 | 2016 | 168757 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4386 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4149 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7659 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7322 | 0.010 |
Why?
|
Genetic Variation | 1 | 2017 | 6544 | 0.010 |
Why?
|
Mice | 2 | 2016 | 81183 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19229 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
Aged | 2 | 2021 | 163280 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21827 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
Male | 3 | 2021 | 350118 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72290 | 0.010 |
Why?
|
Brain | 1 | 2010 | 26385 | 0.010 |
Why?
|